Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 20 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 9464060

    Compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  2. US 9447100

    Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents

    Takeda Pharmaceutical Company Limited · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  3. US 9440990

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  4. US 9440987

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  5. US 9434743

    Indazole derivatives

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  6. US 9433632

    Dry coated tablet

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  7. US 9428470

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  8. US 9427434

    Coated preparation

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  9. US 9403819

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  10. US 9402841

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  11. US 9403802

    Heterocyclic compound and use therefor

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  12. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  13. US 9388195

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  14. US 9382188

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  15. US 9371320

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  16. US 9365540

    Benzimidazole derivatives as MCH receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  17. US 9365520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  18. US 9365566

    Cinnoline derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  19. US 9364438

    Process for producing solid particles

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  20. US 9353108

    Tetrahydronaphthyridine somatostatin receptor 5 antagonists

    Takeda Pharmaceutical Company Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  21. US 9346829

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  22. US 9346783

    Method and apparatus for producing oxidized compound

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  23. US 9346822

    Thienopyrimidine compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  24. US 9346776

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted